Corrigendum to: Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection

“Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection” by Joseph J Carreno et al (Open Forum Infect Dis. 2019. doi:10.1093/ofid/ofz446)

This study was supported by Cipla. It was incorrect to list Achaogen, Inc., as the sponsor. The product Zemdri (Plazomicin) was acquired by Cipla. Cipla is considered the sponsor.

The authors regret this oversight.